lysine methyltransferase 2C pseudogene 1 (KMT2CP1)

KMT2CP1 refers to a pseudogene, not an active protein-coding gene. Pseudogenes like KMT2CP1 lack established biochemical function or therapeutic relevance and are not considered targets for pharmacological intervention. If you are seeking information on the functionally active and therapeutic target Lysine methyltransferase 2C (KMT2C/MLL3), please clarify, as this is a well-studied epigenetic enzyme involved in histone modification, cancer, and gene regulation[1][3][4][5]. If you need information on the active target KMT2C (MLL3), it is important to distinguish it from the non-functional pseudogene KMT2CP1. Pseudogenes such as KMT2CP1 often arise from duplication or retrotransposition events but are generally not transcribed into functional proteins and do not possess the molecular or biological characteristics required of a druggable target.